AKT1 and digestive system neoplasm: Previous studies have shown that the regulation of IR in T2DM is mainly mediated by the PIK3/Akt pathway [16]; therefore, inhibiting PI3K/Akt signaling will likely reduce liver IR and increase insulin sensitivity [17].